相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival
Elena A. Takano et al.
BMC CANCER (2023)
Estrogen Receptor β4 Regulates Chemotherapy Resistance and Induces Cancer Stem Cells in Triple Negative Breast Cancer
Ayesha Bano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Therapeutic Role of Tamoxifen for Triple-Negative Breast Cancer: Leveraging the Interaction Between ERβ and Mutant p53
Lauren Scarpetti et al.
ONCOLOGIST (2023)
Advances in systemic therapies for triple negative breast cancer
Roberto A. Leon-Ferre et al.
BMJ-BRITISH MEDICAL JOURNAL (2023)
Disruption of estrogen receptor beta's DNA binding domain impairs its tumor suppressive effects in triple negative breast cancer
Kirsten G. M. Aspros et al.
FRONTIERS IN MEDICINE (2023)
EGFR is a pivotal player of the E2/ER beta - mediated functional properties, aggressiveness, and stemness in triple-negative breast cancer cells
Konstantina Kyriakopoulou et al.
FEBS JOURNAL (2022)
Estrogen receptor beta 2 (ER beta 2)-mediated upregulation of hsa_circ_0000732 promotes tumor progression via sponging microRNA-1184 in triple-negative breast cancer (TNBC)
Di Chen et al.
INFLAMMATION RESEARCH (2022)
Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer
Kirsten G. M. Aspros et al.
NPJ BREAST CANCER (2022)
The lncRNA XIST mediates sensitivity to ER beta targeted therapies in triple negative breast cancer
Michael J. Emch et al.
CANCER RESEARCH (2022)
Estrogen Receptor-Beta2 (ERβ2)-Mutant p53-FOXM1 Axis: A Novel Driver of Proliferation, Chemoresistance, and Disease Progression in High Grade Serous Ovarian Cancer (HGSOC)
Chetan C. Oturkar et al.
CANCERS (2022)
Immunohistochemical Detection of Estrogen Receptor-Beta (ERβ) with PPZ0506 Antibody in Murine Tissue: From Pitfalls to Optimization
Sarah K. K. Schroeder et al.
BIOMEDICINES (2022)
High GPER expression in triple-negative breast cancer is linked to pro-metastatic pathways and predicts poor patient outcomes
Ting Xu et al.
NPJ BREAST CANCER (2022)
Suppression of G Protein-coupled Estrogen Receptor 1 (GPER1) Enhances the Anti-invasive Efficacy of Selective ERβ Agonists
Vivien Schmitz et al.
ANTICANCER RESEARCH (2022)
Estrogen Receptor Beta 1: A Potential Therapeutic Target for Female Triple Negative Breast Cancer
Parama Dey et al.
ENDOCRINOLOGY (2022)
Epigenetic restoration and activation of ER beta: an inspiring approach for treatment of triple-negative breast cancer
Ahmad Salahuddin et al.
MEDICAL ONCOLOGY (2022)
ERβ Isoforms Have Differential Clinical Significance in Breast Cancer Subtypes and Subgroups
Young Choi et al.
CURRENT ISSUES IN MOLECULAR BIOLOGY (2022)
Contrasting activities of estrogen receptor beta isoforms in triple negative breast cancer
Shunchao Yan et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Estrogen Receptor β-Mediated Inhibition of Actin-Based Cell Migration Suppresses Metastasis of Inflammatory Breast Cancer
Christoforos Thomas et al.
CANCER RESEARCH (2021)
Identification of Novel C-Terminally Truncated Estrogen Receptor β Variant Transcripts and Their Distribution in Humans
Hirotaka Ishii et al.
JOURNAL OF NIPPON MEDICAL SCHOOL (2021)
An updated review on the role of the CXCL8-CXCR1/2 axis in the progression and metastasis of breast cancer
Amaresh Mishra et al.
MOLECULAR BIOLOGY REPORTS (2021)
Impact of cholesterol-pathways on breast cancer development, a metabolic landscape
Alina Gonzalez-Ortiz et al.
JOURNAL OF CANCER (2021)
The Prognostic Value of Estrogen Receptor β Isoform With Correlation of Estrogen Receptor α Among Sudanese Breast Cancer Patients
Manar G. Shalabi et al.
BREAST CANCER-BASIC AND CLINICAL RESEARCH (2021)
Optimized immunohistochemical detection of estrogen receptor beta using two validated monoclonal antibodies confirms its expression in normal and malignant breast tissues
John R. Hawse et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Interaction Proteomics Identifies ERbeta Association with Chromatin Repressive Complexes to Inhibit Cholesterol Biosynthesis and Exert An Oncosuppressive Role in Triple-negative Breast Cancer
Elena Alexandrova et al.
MOLECULAR & CELLULAR PROTEOMICS (2020)
Ventral prostate and mammary gland phenotype in mice with complete deletion of the ERβ gene
Margaret Warner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Estrogen receptor β exerts tumor suppressive effects in prostate cancer through repression of androgen receptor activity
Surendra Chaurasiya et al.
PLOS ONE (2020)
Elevated estrogen receptor β expression in triple negative breast cancer cells is associated with sensitivity to doxorubicin by inhibiting the PI3K/AKT/mTOR signaling pathway
Shanshan Lei et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2020)
Small Non-Coding RNA Profiling Identifies miR-181a-5p as a Mediator of Estrogen Receptor Beta-Induced Inhibition of Cholesterol Biosynthesis in Triple-Negative Breast Cancer
Elena Alexandrova et al.
CELLS (2020)
ΕGFR/ERβ-Mediated Cell Morphology and Invasion Capacity Are Associated with Matrix Culture Substrates in Breast Cancer
Konstantina Kyriakopoulou et al.
CELLS (2020)
Circulating 27-hydroxycholesterol and breast cancer tissue expression of CYP27A1, CYP7B1, LXR-β, and ERβ: results from the EPIC-Heidelberg cohort
Charlotte Le Cornet et al.
BREAST CANCER RESEARCH (2020)
Response to mTOR and PI3K inhibitors in enzalutamide-resistant luminal androgen receptor triple-negative breast cancer patient-derived xenografts
Florence Coussy et al.
THERANOSTICS (2020)
Estrogen receptor beta increases sensitivity to enzalutamide in androgen receptor-positive triple-negative breast cancer
Aristomenis Anestis et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer
Utpal K. Mukhopadhyay et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Estrogen receptor β inhibits breast cancer cells migration and invasion through CLDN6-mediated autophagy
Peiye Song et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Impact of Nuclear Oestrogen Receptor Beta Expression in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
Florian Heitz et al.
GEBURTSHILFE UND FRAUENHEILKUNDE (2019)
Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
Rainer Girgert et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Endogenous expression of ERβ variants contributes towards chemotherapy-resistance in the triple negative breast cancer cell line HCC-1806
M. Faria et al.
CANCER RESEARCH (2019)
Estrogen receptor beta elicits anti-cancer effects in triple negative breast cancer through suppression of NFκB signaling
K. Aspros et al.
CANCER RESEARCH (2019)
IMP2 and IMP3 cooperate to promote the metastasis of triple-negative breast cancer through destabilization of progesterone receptor
Hye-Youn Kim et al.
CANCER LETTERS (2018)
Estrogen receptor subtypes dictate the proliferative nature of the mammary gland
Genevieve V. Dall et al.
JOURNAL OF ENDOCRINOLOGY (2018)
The ERβ4 variant induces transformation of the normal breast mammary epithelial cell line MCF-10A; the ERβ variants ERβ2 and ERβ5 increase aggressiveness of TNBC by regulation of hypoxic signaling
Michelle Faria et al.
Oncotarget (2018)
Estrogen receptor β and estrogen receptor α36 predict differential outcome of patients with breast cancer
Zi-Han Sun et al.
TRANSLATIONAL CANCER RESEARCH (2018)
ERβ-mediated induction of cystatins results in suppression of TGFβ signaling and inhibition of triple-negative breast cancer metastasis
Jordan M. Reese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Estrogen receptor-beta is a potential target for triple negative breast cancer treatment
David Austin et al.
Oncotarget (2018)
Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential
Lu Gan et al.
BIOMARKER RESEARCH (2018)
Differential Activation of a Mouse Estrogen Receptor β Isoform (mERβ2) with Endocrine-Disrupting Chemicals (EDCs)
Lauren J. Donoghue et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2017)
ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
Wei Song et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity
Adam W. Nelson et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
Insufficient antibody validation challenges oestrogen receptor beta research
Sandra Andersson et al.
NATURE COMMUNICATIONS (2017)
ER?β inhibits cyclin dependent kinases 1 and 7 in triple negative breast cancer
Jordan M. Reese et al.
ONCOTARGET (2017)
Estrogen receptor beta 2 induces proliferation and invasiveness of triple negative breast cancer cells; association with regulation of PHD3 and HIF-1 alpha
Lucia Bialesova et al.
ONCOTARGET (2017)
Estrogen receptor β2 and β5 increase expression of ABCG2 and drug resistance of the triple-negative breast cancer cell line SUM159
M. Faria et al.
CANCER RESEARCH (2017)
A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)
H. Bonnefoi et al.
ANNALS OF ONCOLOGY (2016)
Estrogen receptor β promoter methylation: a potential indicator of malignant changes in breast cancer
Lei Gao et al.
ARCHIVES OF MEDICAL SCIENCE (2016)
ERβ decreases the invasiveness of triple-negative breast cancer cells by regulating mutant p53 oncogenic function
Igor Bado et al.
ONCOTARGET (2016)
Oxidative Dimerization of PHD2 is Responsible for its Inactivation and Contributes to Metabolic Reprogramming via HIF-1α Activation
Gibok Lee et al.
SCIENTIFIC REPORTS (2016)
Estrogen receptor-beta in mitochondria: implications for mitochondrial bioenergetics and tumorigenesis
Tien-Ling Liao et al.
MITOCHONDRIAL RESEARCH IN TRANSLATIONAL MEDICINE (2015)
ERβ Expression and Breast Cancer Risk Prediction for Women with Atypias
Tina J. Hieken et al.
CANCER PREVENTION RESEARCH (2015)
Mitochondrial estrogen receptor β2 drives antiapoptotic pathways in advanced serous ovarian cancer
Alessandra Ciucci et al.
HUMAN PATHOLOGY (2015)
Oestrogen receptors β1 and βcx have divergent roles in breast cancer survival and lymph node metastasis
G. Rosin et al.
BRITISH JOURNAL OF CANCER (2014)
GPER Mediates Activation of HIF1α/VEGF Signaling by Estrogens
Ernestina Marianna De Francesco et al.
CANCER RESEARCH (2014)
Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis
Antti Arjonen et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
被撤回的出版物: Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells (Retracted article. See vol. 119, 2022)
Debangshu Samanta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
Ayca Gucalp et al.
CLINICAL CANCER RESEARCH (2013)
Estrogen receptor beta 2 is associated with poor prognosis in estrogen receptor alpha-negative breast carcinoma
Miki I. Chantzi et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Research Resource: Global Identification of Estrogen Receptor β Target Genes in Triple Negative Breast Cancer Cells
Erin K. Shanle et al.
MOLECULAR ENDOCRINOLOGY (2013)
Estrogen receptor β sustains epithelial differentiation by regulating prolyl hydroxylase 2 transcription
Paul Mak et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance
Karthika Natarajan et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Hypoxia-inducible factor-2a is associated with ABCG2 expression, histology-grade and Ki67 expression in breast invasive ductal carcinoma
Lei Xiang et al.
DIAGNOSTIC PATHOLOGY (2012)
Regulation of IMP3 by EGFR signaling and repression by ERβ: implications for triple-negative breast cancer
S. Samanta et al.
ONCOGENE (2012)
ER beta 1 represses basal-like breast cancer epithelial to mesenchymal transition by destabilizing EGFR
Christoforos Thomas et al.
BREAST CANCER RESEARCH (2012)
TGF-β Signaling in Breast Cancer Cell Invasion and Bone Metastasis
Yvette Drabsch et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2011)
The different roles of ER subtypes in cancer biology and therapy
Christoforos Thomas et al.
NATURE REVIEWS CANCER (2011)
Genome-Wide Mapping of Estrogen Receptor-β-Binding Regions Reveals Extensive Cross-Talk with Transcription Factor Activator Protein-1
Chunyan Zhao et al.
CANCER RESEARCH (2010)
Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation
Leo A. Niemeier et al.
MODERN PATHOLOGY (2010)
Genome-Wide Dynamics of Chromatin Binding of Estrogen Receptors alpha and beta : Mutual Restriction and Competitive Site Selection
Tze Howe Charn et al.
MOLECULAR ENDOCRINOLOGY (2010)
Mutant p53 mediates survival of breast cancer cells
L. Y. Lim et al.
BRITISH JOURNAL OF CANCER (2009)
Tumor-derived Matrix Metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer
Bin Zhang et al.
BMC CANCER (2008)
TGFβ primes breast tumor cells for metastasis
Alana L. Welm
CELL (2008)
The potential role of ER beta isoforms in the clinical management of breast cancer
C. A. Green et al.
HISTOPATHOLOGY (2008)
Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers
Yoshinari Ogawa et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2008)
Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway
William G. Kaelin et al.
MOLECULAR CELL (2008)
Estrogen receptor (ER)-β isoforms:: A key to understanding ER-β signaling
Yuet-Kin Leung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Estrogen receptor α-negative breast cancer tissues express significant levels of estrogen-independent transcription factors, ERβ1 and ERβ5:: Potential molecular targets for chernoprevention
I Poola et al.
CLINICAL CANCER RESEARCH (2005)
Estrogen receptors beta4 and Beta5 are full length functionally distinct ERβ isoforms -: Cloning from human ovary and functional characterization
I Poola et al.
ENDOCRINE (2005)
Mouse estrogen receptor β isoforms exhibit differences in ligand selectivity and coactivator recruitment
CY Zhao et al.
BIOCHEMISTRY (2005)
Increased estrogen receptor βcx expression during mammary carcinogenesis
M Esslimani-Sahla et al.
CLINICAL CANCER RESEARCH (2005)
Breast cancer resistance protein (BCRP/ABCG2)
F Staud et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
Mitochondrial localization of estrogen receptor β
SH Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Differential distribution of splice variants of estrogen receptor beta in human testicular cells suggests specific functions in spermatogenesis
EL Aschim et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2004)
The expression of oestrogen receptor (ER)-β and its variants, but not ERα, in adult human mammary fibroblasts
C Palmieri et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2004)
The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme
P Krishnamurthy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Mitochondrial localization of ERα and ERβ in human MCF7 cells
JQ Chen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
The favourable prognostic value of oestrogen receptor β immunohistochemical expression in breast cancer
L Nakopoulou et al.
JOURNAL OF CLINICAL PATHOLOGY (2004)
Stable transfection of an estrogen receptor beta cDNA isoform into MDA-MB-231 breast cancer cells
DA Tonetti et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2003)
Reduced expression of oestrogen receptor β in invasive breast cancer and its re-expression using DNA methyl transferase inhibitors in a cell line model
GP Skliris et al.
JOURNAL OF PATHOLOGY (2003)
Declining estrogen receptor-beta expression defines malignant progression of human breast neoplasia
AM Shaaban et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
The novel 5 '-untranslated first exon, exon 0H, of the rat estrogen receptor beta gene
H Iwamoto et al.
ENDOCRINE RESEARCH (2003)
Involvement of estrogen receptor β in terminal differentiation of mammary gland epithelium
C Förster et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Distinct expression patterns of ERα and ERβ in normal human mammary gland
V Speirs et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
Expression of estrogen receptor beta isoforms in human breast cancer tissues and cell lines
D Tong et al.
BREAST CANCER RESEARCH AND TREATMENT (2002)
Estrogen receptor antibodies: specificity and utility in detection, localization and analyses of estrogen receptor alpha and beta
M Pavao et al.
STEROIDS (2001)
分享论文
